Axxcess Wealth Management LLC boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 32.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,602 shares of the biotechnology company's stock after purchasing an additional 388 shares during the period. Axxcess Wealth Management LLC's holdings in Axon Enterprise were worth $1,326,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Hemington Wealth Management lifted its stake in shares of Axon Enterprise by 70.8% in the 2nd quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company's stock valued at $33,000 after acquiring an additional 17 shares during the last quarter. TCTC Holdings LLC grew its holdings in Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock worth $29,000 after acquiring an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC grew its holdings in Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after acquiring an additional 33 shares during the period. Catalyst Capital Advisors LLC acquired a new stake in shares of Axon Enterprise in the 1st quarter valued at about $32,000. Finally, Banque Transatlantique SA acquired a new stake in shares of Axon Enterprise in the 1st quarter valued at about $31,000. 79.08% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
AXON has been the topic of several recent research reports. Needham & Company LLC reaffirmed a "buy" rating and issued a $870.00 price target on shares of Axon Enterprise in a research report on Wednesday, September 24th. Bank of America lifted their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Northland Securities set a $800.00 target price on shares of Axon Enterprise in a research report on Tuesday, August 5th. Craig Hallum upgraded shares of Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 price target for the company in a research note on Tuesday, August 5th. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Axon Enterprise in a research note on Wednesday, October 8th. Fourteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise presently has a consensus rating of "Moderate Buy" and an average target price of $841.64.
Read Our Latest Stock Analysis on Axon Enterprise
Insiders Place Their Bets
In other Axon Enterprise news, CFO Brittany Bagley sold 5,000 shares of the stock in a transaction that occurred on Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the transaction, the chief financial officer directly owned 93,592 shares in the company, valued at approximately $66,813,456.96. This trade represents a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Joshua Isner sold 15,919 shares of the stock in a transaction on Friday, August 15th. The stock was sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the sale, the president directly owned 238,379 shares of the company's stock, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 59,932 shares of company stock valued at $45,115,616. Insiders own 4.40% of the company's stock.
Axon Enterprise Stock Performance
Axon Enterprise stock opened at $644.99 on Thursday. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $50.63 billion, a PE ratio of 159.26, a P/E/G ratio of 27.36 and a beta of 1.41. The firm has a fifty day simple moving average of $747.25 and a two-hundred day simple moving average of $715.49. Axon Enterprise, Inc has a twelve month low of $422.38 and a twelve month high of $885.91.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm's revenue for the quarter was up 32.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.